GRP
AKRO

Global Retirement Partners’s Akero Therapeutics AKRO Stock Holding History

Global Retirement Partners’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,523
Closed -$72.3K – 4234
2025
Q3 		$72.3K Sell
1,523
-400
-21% -$19.4K ﹤0.01% 1690
2025
Q2 		$103K Buy
+1,923
New +$87.4K ﹤0.01% 1425
2024
Q4 		$137K Sell
4,917
-740
-13% -$22.4K ﹤0.01% 1119
2024
Q3 		$162K Buy
5,657
+175
+3% +$4.56K ﹤0.01% 1000
2024
Q2 		$129K Sell
5,482
-265
-5% -$5.67K ﹤0.01% 1071
2024
Q1 		$145K Buy
5,747
+2,028
+55% +$48.7K 0.01% 919
2023
Q4 		$81.9K Sell
3,719
-560
-13% -$11K ﹤0.01% 1144
2023
Q3 		$197K Sell
4,279
-100
-2% -$4.66K 0.01% 668
2023
Q2 		$204K Buy
+4,379
New +$201K 0.01% 696

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Global Retirement Partners's AKRO Position: Q4 2025 in Review

Global Retirement Partners sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 1,523 shares — an estimated $72.3K sold.

Global Retirement Partners first reported a position in AKRO in Q2 2023 and held it in 9 quarters. The position peaked at $204K in Q2 2023. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Global Retirement Partners reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Global Retirement Partners sold 1,523 Akero Therapeutics shares in Q4 2025, an estimated $72.3K.
  • Global Retirement Partners first reported a position in Akero Therapeutics in Q2 2023 and held it in 9 quarters.
  • Global Retirement Partners's Akero Therapeutics position peaked at $204K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.